全球眼科器材市场－2025-2030年预测

预计眼科设备市场将从 2025 年的 212.38 亿美元成长到 2030 年的 292.35 亿美元，复合年增长率为 6.60%。

由于视力障碍病例增加、人口老化以及生活方式的改变，眼科疾病的盛行率不断上升，全球眼科器械市场预计将迎来显着增长。眼科器械对于矫正白内障、青光眼、视网膜疾病、糖尿病眼科疾病等引起的视力问题至关重要，同时也有助于近视和远视患者实现无镜片视力。随着可支配收入的增加、技术创新以及在预防可预防性失明方面投入的不断增长，人们对先进治疗方法的需求日益增加，预计该市场将继续扩张。

市场驱动因素

视力障碍和可预防性失明的增加

视力障碍的日益增多是眼科成长要素。各国政府和卫生组织越来越关注可预防性失明，并因此增加对视力保健的投入。白内障是导致可预防性失明的主要原因，每年影响1亿隻眼睛，尤其是在老年人族群。青光眼每年影响超过6000万人，逐渐损害视神经。同时，干眼症每年影响超过3.34亿患者，导致视力障碍。视网膜疾病，包括糖尿病黄斑部水肿（DME）和视网膜静脉阻塞（RVO），每年导致2000万至2500万人严重失明。糖尿病、心血管疾病和肥胖等慢性疾病加剧了这一风险，占全球每年死亡人数的51%。预计到2050年，约有48亿人（占世界人口的一半）将患有近视，这将进一步推动对眼科设备的需求。诺华等公司正在开发用于治疗青光眼的神经保护疗法，这表明该行业致力于透过创新解决方案来应对这些挑战。

生活方式和职场环境的变化

现代生活方式的趋势，尤其是智慧型手机、平板电脑和智慧电视等电子设备的日益普及，正在加剧各个年龄层的视力问题。长时间的萤幕使用，加上远距办公和线上教育的盛行，给视神经造成了巨大的压力，并导致近视和远视的增加。这种职场文化的转变，加上远距办公的持续发展，使得学生和职场人士的萤幕使用时间不断增加，视力矫正设备的需求也随之扩大。数位设备的日益普及凸显了开发先进的眼科解决方案以缓解相关眼部疲劳和视力问题的必要性。

市场展望

受人口老化和慢性疾病（这些疾病会加剧眼科疾病）的推动，眼科器材市场预计到2030年将保持强劲成长。视力矫正和治疗设备的科技进步，以及医疗保健投资的不断增长，进一步提振了市场前景。可支配收入的快速增长支撑了对高品质治疗的需求，而与生活方式相关的视力问题也确保了各类人群对眼科解决方案的需求。产业相关人员必须优先考虑创新和可及性，才能抓住这些成长机会，同时应对全球视力保健挑战，尤其是在中低收入国家，因为89%的视觉障碍者居住在这些国家。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2022-2024 年）和预测资料（2025-2030 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 全球眼科器材市场（按类型划分）

• 介绍
• 手术器械
  • 持针器
  • 钳子
  • 牵开器/眼底镜
  • 其他的
• 诊断设备
  • 眼底镜
  • 眼压计
  • 分析器
  • 其他的
• 视力保健产品
  • 隐形眼镜
  • 眼镜
• 其他的

6. 全球眼科设备市场（按应用划分）

• 介绍
• 白内障
• 青光眼
• 屈光不正
  • 近视
  • 远见
• 其他的

7. 全球眼科设备市场（依最终用户划分）

• 介绍
• 医院和诊所
• 门诊手术中心
• 其他的

8. 全球眼科器材市场（按地区划分）

• 介绍
• 北美洲
  • 按类型
  • 透过使用
  • 最终用户
  • 按国家/地区
    • 美国
    • 加拿大
    • 墨西哥
• 南美洲
  • 按类型
  • 透过使用
  • 最终用户
  • 按国家/地区
    • 巴西
    • 阿根廷
    • 其他的
• 欧洲
  • 按类型
  • 透过使用
  • 最终用户
  • 按国家/地区
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
• 中东和非洲
  • 按类型
  • 透过使用
  • 最终用户
  • 按国家/地区
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
• 亚太地区
  • 按类型
  • 透过使用
  • 最终用户
  • 按国家/地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• Johnson & Johnson
• Bausch & Lomb Incorporated
• Carl Zeiss AG
• Essilor
• Nidek Co Ltd
• Topcon Corporation
• Ziemer Ophthalmic Systems
• Alcon Vision LLC
• Hoya Corporation
• Haag-Streit Group

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The Ophthalmic Devices Market will grow from USD 21.238 billion in 2025 to USD 29.235 billion by 2030, fueled by a 6.60% compound annual growth rate (CAGR).

The global ophthalmic devices market is poised for significant growth, driven by rising vision impairment cases, an aging population, and lifestyle changes increasing the prevalence of eye disorders. Ophthalmic devices, essential for correcting vision issues caused by conditions like cataracts, glaucoma, retinal disorders, and diabetic eye problems, also facilitate lens-free vision for myopia and hyperopia. The market is expected to expand due to heightened demand for advanced treatments, fueled by growing disposable incomes, technological innovations, and increased investments in combating preventable blindness.

Market Drivers

Rising Vision Impairment and Preventable Blindness

The escalating prevalence of vision impairment is a primary growth driver. Governments and health organizations are increasingly concerned about preventable blindness, prompting significant investments in vision care. Cataracts, a leading cause of preventable blindness, affect 100 million eyes annually, particularly among the aging population. Glaucoma, impacting over 60 million people yearly, progressively damages the optic nerve, while dry eye disease affects more than 334 million patients annually, impairing vision. Retinal diseases, including Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO), cause severe vision loss in 20-25 million people each year, with risks amplified by chronic conditions like diabetes, cardiovascular diseases, and obesity, which account for 51% of global deaths annually. By 2050, approximately 4.8 billion people-half the global population-are projected to have myopic vision, further driving demand for ophthalmic devices. Companies like Novartis are advancing neuroprotective therapies for glaucoma, underscoring the industry's focus on innovative solutions to address these challenges.

Lifestyle Changes and Work Culture

Modern lifestyle trends, particularly the increased use of electronic devices such as smartphones, tablets, and smart TVs, are intensifying vision-related issues across all age groups. Prolonged screen time, exacerbated by remote work and digital education, significantly strains optic nerves, contributing to a rise in myopia and hyperopia. This shift in work culture, with sustained remote operations, has expanded the patient base for vision correction devices, as screen time continues to increase among both students and professionals. The growing penetration of digital devices underscores the need for advanced ophthalmic solutions to mitigate associated eye strain and vision impairment.

Market Outlook

The ophthalmic devices market is set to grow robustly through 2030, propelled by the rising geriatric population and chronic disease prevalence, which exacerbate eye conditions. Technological advancements in vision correction and treatment devices, coupled with increased healthcare investments, will enhance market prospects. The surge in disposable incomes supports demand for high-quality treatments, while lifestyle-driven vision issues ensure a broad demographic need for ophthalmic solutions. Industry stakeholders must prioritize innovation and accessibility, particularly in low- and middle-income countries where 89% of vision-impaired individuals reside, to capitalize on these growth opportunities while addressing global vision care challenges.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

• Surgical Device
• Needle Holders
• Forceps
• Retractors & Speculum
• Others
• Diagnostics Device
• Ophthalmoscope
• Tonometer
• Phoropter
• Others
• Vision Care Products
• Contact Lenses
• Spectacles
• Others

By Application

• Cataract
• Glaucoma
• Refractive Errors
• Myopia
• Hyperopia
• Others

By End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL OPHTHALMIC DEVICES MARKET BY TYPE

• 5.1. Introduction
• 5.2. Surgical Device
  • 5.2.1. Needle Holders
  • 5.2.2. Forceps
  • 5.2.3. Retractors & Speculum
  • 5.2.4. Others
• 5.3. Diagnostics Device
  • 5.3.1. Ophthalmoscope
  • 5.3.2. Tonometer
  • 5.3.3. Phoropter
  • 5.3.4. Others
• 5.4. Vision Care Products
  • 5.4.1. Contact Lenses
  • 5.4.2. Spectacles
• 5.5. Others

6. GLOBAL OPHTHALMIC DEVICES MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Cataract
• 6.3. Glaucoma
• 6.4. Refractive Errors
  • 6.4.1. Myopia
  • 6.4.2. Hyperopia
• 6.5. Others

7. GLOBAL OPHTHALMIC DEVICES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hopsitals & Clinics
• 7.3. Ambulatory Surgical Centers
• 7.4. Others

8. GLOBAL OPHTHALMIC DEVICES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Type
  • 8.3.2. By Application
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Type
  • 8.4.2. By Application
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. Germany
    • 8.4.4.2. France
    • 8.4.4.3. United Kingdom
    • 8.4.4.4. Italy
    • 8.4.4.5. Spain
    • 8.4.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Type
  • 8.5.2. By Application
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Israel
    • 8.5.4.4. Others
• 8.6. Asia Pacific
  • 8.6.1. By Type
  • 8.6.2. By Application
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. India
    • 8.6.4.3. Japan
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Thailand
    • 8.6.4.7. Taiwan
    • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Johnson & Johnson
• 10.2. Bausch & Lomb Incorporated
• 10.3. Carl Zeiss AG
• 10.4. Essilor
• 10.5. Nidek Co Ltd
• 10.6. Topcon Corporation
• 10.7. Ziemer Ophthalmic Systems
• 10.8. Alcon Vision LLC
• 10.9. Hoya Corporation
• 10.10. Haag-Streit Group

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations